News

Introducing the Jumpstarting Brain Tumor Drug Development Coalition We first told you about our Clinical Trial Endpoints Initiative back in late June of 2013. We then let the Chair of the Initiative’s Steering Committee, Dr. Patrick Wen of Dana-Farber Cancer Institute, explain the promise of this effort further in a video interview we posted back in December. Now, we’d like to introduce you […] January 28, 2014

Advancing Research to Therapies Conference Connects Field National Brain Tumor Society hosted the inaugural Advancing Research to Therapies (ART) for Brain Tumors Conference in Washington, D.C. during Brain Tumor Awareness Month in May 2013. The ART Conference brought together more than 100 leading experts from academic research labs, government agencies, biotech and pharmaceutical companies, and venture capital firms to discuss faster commercialization […] July 23, 2013